Citations 2
Preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by chemoradiation (CRT) for borderline resectable (BLR) pancreatic cancer (PDAC): Initial results from Alliance Trial A021101.
Ahmad, Syed A. , Marsh, Robert , Collisson, Eric A. , Schwartz, Lawrence H., Martin, Robert C.G. , Conway, William, Truty, Mark J. , Kindler, Hedy L. , Lowy, Andrew M. , Philip, Philip Agop, Cardin, Dana B. , LoConte, Noelle K. , Cardin, Dana B , LoConte, Noelle , Katz, Matthew H. G. , Shi, Qian , Herman, Joseph M. , Bekaii‐Saab, Tanios , Venook, Alan P.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4008-4008
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
Katz, Matthew H. G. , Shi, Qian , Herman, Joseph M. , Marsh, Robert , Collisson, Eric A. , Schwartz, Lawrence H., Frankel, Wendy L. , Martin, Robert C.G. , Conway, William, Truty, Mark J. , Kindler, Hedy L. , Lowy, Andrew M. , Bekaii‐Saab, Tanios , Philip, Philip, Cardin, Dana B. , LoConte, Noelle K. , Shen, Perry , Hoffman, John P., Truty, Mark, Ahmad, Syed Ameen , Talamonti, Marina , Venook, Alan P. , Cardin, Dana B , Shi, Qian , LoConte, Noelle , Bekaii-Saab, Tanios S , Katz, Matthew H G
JAMA Surgery | June 8, 2016 | Volume: 151 | Issue: 8 | Pages: e161137